Physician profile
Patrick S Comegys
NPI 1336446798
$803.06
in general payments reported to CMS, 2019-2025
13 companies · $62.24 in 2025
The $62.24 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $147 · 2023: $108 · 2024: $51.93 · 2025: $62.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $223.27 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $199.98 | 2021-2025 | Euflexxa |
| Abbott Laboratories | $140.66 | 2021-2024 | Proclaim |
| Pacira Therapeutics, INC. | $43.40 | 2021 | |
| Janssen Biotech, INC. | $37.63 | 2025 | Tremfya |
| Nevro Corp. | $24.66 | 2021 | |
| Ibsa Pharma INC. | $24.44 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.64 | 2022 | |
| Neurocrine Biosciences, INC. | $19.39 | 2023 | Ingrezza |
| Scilex Pharmaceuticals INC. | $18.50 | 2021 | |
| Medline Industries LP | $17.03 | 2022 | |
| Nalu Medical, INC. | $15.83 | 2022 | |
| Fidia Pharma USA INC. | $14.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Comegys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.